1. Home
  2. SOR vs PRME Comparison

SOR vs PRME Comparison

Compare SOR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOR
  • PRME
  • Stock Information
  • Founded
  • SOR 1968
  • PRME 2019
  • Country
  • SOR United States
  • PRME United States
  • Employees
  • SOR N/A
  • PRME N/A
  • Industry
  • SOR Investment Managers
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • SOR Finance
  • PRME Health Care
  • Exchange
  • SOR Nasdaq
  • PRME Nasdaq
  • Market Cap
  • SOR 361.3M
  • PRME 424.9M
  • IPO Year
  • SOR N/A
  • PRME 2022
  • Fundamental
  • Price
  • SOR $45.26
  • PRME $2.88
  • Analyst Decision
  • SOR
  • PRME Strong Buy
  • Analyst Count
  • SOR 0
  • PRME 9
  • Target Price
  • SOR N/A
  • PRME $13.13
  • AVG Volume (30 Days)
  • SOR 16.2K
  • PRME 1.1M
  • Earning Date
  • SOR 01-01-0001
  • PRME 11-12-2024
  • Dividend Yield
  • SOR 7.24%
  • PRME N/A
  • EPS Growth
  • SOR N/A
  • PRME N/A
  • EPS
  • SOR 6.50
  • PRME N/A
  • Revenue
  • SOR N/A
  • PRME $800,000.00
  • Revenue This Year
  • SOR N/A
  • PRME N/A
  • Revenue Next Year
  • SOR N/A
  • PRME $426.55
  • P/E Ratio
  • SOR $6.41
  • PRME N/A
  • Revenue Growth
  • SOR N/A
  • PRME N/A
  • 52 Week Low
  • SOR $36.41
  • PRME $2.81
  • 52 Week High
  • SOR $42.75
  • PRME $9.80
  • Technical
  • Relative Strength Index (RSI)
  • SOR 54.60
  • PRME 37.56
  • Support Level
  • SOR $44.00
  • PRME $2.81
  • Resistance Level
  • SOR $45.47
  • PRME $3.04
  • Average True Range (ATR)
  • SOR 0.65
  • PRME 0.21
  • MACD
  • SOR -0.05
  • PRME -0.01
  • Stochastic Oscillator
  • SOR 49.57
  • PRME 8.50

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: